Canton, Mich. (March 14, 2016) — MMS Holdings Inc., a specialty data-focused CRO, has announced a $1M award toward the development of a Zika vaccine. The award is being offered as data services to qualified pharmaceutical companies supporting the commercial...
HYDERABAD (January 26, 2016) — MMS Holdings Inc. (www.mmsholdings.com) is pleased to announce the opening of a new office in Hyderabad, India. The company’s Asia headquarters are located in Bangalore, India and the company’s ability to deliver exceptional quality...
Canton, Mich. (June 11, 2014) – MMS Holdings Inc., a clinical research organization that focuses on regulatory submission support for the pharmaceutical and biotech industries, and the Wayne State University (WSU) Graduate School announced today the creation of a...
Canton, Mich. (August 1, 2013) – MMS Holdings Inc. today announced that it has been selected to partner with Knopp Biosciences to provide best-in-class pharmacovigilance services in support of their compound, dexpramipexole. The MMS Holdings team offers an efficient,...